Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer
- PMID: 26366382
- PMCID: PMC4559615
- DOI: 10.4174/astr.2015.89.3.131
Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer
Abstract
Purpose: The objective of this study was to assess the clinical outcomes of pelvic exenteration for patients with primary locally advanced colorectal cancer (LACRC) or locally recurrent colorectal cancer (LRCRC), and to identify clinically relevant prognostic factors.
Methods: Between January 2001 and December 2010, 40 consecutive patients with primary LACRC or LRCRC underwent pelvic exenteration at the National Cancer Center, Republic of Korea. We retrospectively reviewed their medical records.
Results: The median age was 59 years and the median follow-up time was 26 months (range, 1-117 months). The overall complication and in-hospital mortality rates were 70% (28/40) and 7.5% (3/40), respectively. The complication rates were similar between patients with primary LACRC (69.6%) and those with LRCRC (70.6%). The overall recurrence rate was 50% (17/34), and was lower in patients with primary LACRC than in patients with LRCRC (33.3% vs. 76.9%, P = 0.032). The 5-year overall survival was significantly different between primary LACRC and patients with LRCRC (58.7% vs. 11.8%, P = 0.022). Multivariate analysis revealed that radicality (R0 vs. R1/R2) was an independent prognostic factor for overall survival (P = 0.020).
Conclusion: The complication and operative mortality rates of pelvic exenteration remained high, but pelvic exenteration might provide an opportunity for long-term survival and good local control. Complete (R0) resection was the only independent prognostic factor for overall survival.
Keywords: Colorectal neoplasms; Local neoplasm recurrences; Pelvic exenteration.
Conflict of interest statement
Figures



Similar articles
-
Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.Tech Coloproctol. 2018 Nov;22(11):835-845. doi: 10.1007/s10151-018-1883-1. Epub 2018 Dec 1. Tech Coloproctol. 2018. PMID: 30506497
-
Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer.Dis Colon Rectum. 2003 Dec;46(12):1619-25. doi: 10.1007/BF02660766. Dis Colon Rectum. 2003. PMID: 14668586
-
Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome.Int J Colorectal Dis. 2021 Aug;36(8):1701-1710. doi: 10.1007/s00384-021-03893-y. Epub 2021 Mar 7. Int J Colorectal Dis. 2021. PMID: 33677655 Free PMC article.
-
Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.Ann Surg. 2014 Feb;259(2):315-22. doi: 10.1097/SLA.0b013e31828a0d22. Ann Surg. 2014. PMID: 23478530
-
Surgical approach in locally advanced colorectal cancer--combined, extended and compound surgery.Khirurgiia (Sofiia). 2013;(4):29-50. Khirurgiia (Sofiia). 2013. PMID: 24800318 Review. Bulgarian, English.
Cited by
-
Combined transabdominal and transperineal endoscopic pelvic exenteration for colorectal cancer: feasibility and safety of a two-team approach.Ann Surg Treat Res. 2021 Aug;101(2):102-110. doi: 10.4174/astr.2021.101.2.102. Epub 2021 Jul 29. Ann Surg Treat Res. 2021. PMID: 34386459 Free PMC article.
-
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.BMC Cancer. 2022 May 6;22(1):504. doi: 10.1186/s12885-022-09561-w. BMC Cancer. 2022. PMID: 35524234 Free PMC article.
-
Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.Tech Coloproctol. 2018 Nov;22(11):835-845. doi: 10.1007/s10151-018-1883-1. Epub 2018 Dec 1. Tech Coloproctol. 2018. PMID: 30506497
-
Review of incomplete macroscopic resections (R2) in rectal cancer: Treatment, prognosis and future perspectives.World J Gastrointest Oncol. 2021 Sep 15;13(9):1062-1072. doi: 10.4251/wjgo.v13.i9.1062. World J Gastrointest Oncol. 2021. PMID: 34616512 Free PMC article. Review.
-
Patterns of Care and Oncologic Outcomes after Pelvic Exenteration for Locally Advanced Rectal Cancer in the United States.Ann Surg Oncol. 2025 Apr;32(4):2271-2281. doi: 10.1245/s10434-024-16608-8. Epub 2024 Dec 1. Ann Surg Oncol. 2025. PMID: 39617860
References
-
- Winter DC, Walsh R, Lee G, Kiely D, O'Riordain MG, O'Sullivan GC. Local involvement of the urinary bladder in primary colorectal cancer: outcome with enbloc resection. Ann Surg Oncol. 2007;14:69–73. - PubMed
-
- Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2006;13:612–623. - PubMed
-
- Rahbari NN, Ulrich AB, Bruckner T, Munter M, Nickles A, Contin P, et al. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure. Ann Surg. 2011;253:522–533. - PubMed
-
- Wanebo HJ, Antoniuk P, Koness RJ, Levy A, Vezeridis M, Cohen SI, et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum. 1999;42:1438–1448. - PubMed
-
- Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948;1:177–183. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources